drugset
drugset / Trial / NCT01790607

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

NCT01790607 ↗

Phase 1 Completed 20 enrolled Ono Pharma USA Inc Ono Pharmaceutical Co., Ltd. · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate and compare the pharmacokinetics and safety of ONO-2745/CNS 7056 in subjects with the hepatic impairment and matched healthy subjects.

Timeline

Start
2013-02
Primary completion
2013-11
Completion
—

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule 0.1 mg/kg Intravenous

Indications

No indication recorded.